Thomas R Pieber

Endocrinology — Geriatrische Gesundheitszentren, Austria

LeadR Profile

Thomas R Pieber Geriatrische Gesundheitszentren Austria
2 521 ScienceLeadR Reputation 2521
Network Map

Endocrinology

Subspecialties: Cardiology - Biochemistry - Dermatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1993 - 2026

Source: PubMed

University of Graz

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 675

Citations

Citations: 37 023 1st author: 29 Last author: 150 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Transcriptomics of type 1 diabetes progression: a validation study in newly diagnosed patients.
diabetes mellitus, genes, biomedical research, disease progression, diagnosis, therapeutics, diabetes mellitus, type 1, gene expression
EBioMedicine20260
Exercise or Fasting in Individuals With Type 2 Diabetes Receiving Once-Weekly Basal Insulin Icodec.
diabetes mellitus, exercise, fasting, insulin, carbohydrates, diabetes mellitus, type 2
Diabetes Obes Metab20260
Presenilin-1 controls glycolysis and identity of pancreatic beta cells.
cells, biological science disciplines, insulin-secreting cells, homeostasis, presenilins, presenilin-1
Commun Biol20260
Targeting Inflammation in Obesity and the Cardiovascular-Kidney-Metabolic (CKM) Syndrome Spectrum: A Narrative Review.
diabetes mellitus, multiple chronic conditions, kidney, liver, obesity, therapeutics, peroxisome proliferator-activated receptors
Obes Facts20260
Enzymatic 2-Hydroxybutyrate Measurement for Dysglycemia Screening Beyond Conventional Fasting Measures.
diabetes mellitus, research design, fasting, biomarkers
Diabetes Care20260

Clinical Studies 75

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 30 Study Chair: 1 Study Director: 2

By phase:

N/A 32
Phase 3 16
Phase 1 13
Phase 2 11
Phase 4 3

By status:

Completed 69
Terminated 3
Recruiting 2
Unknown 1

By type:

Interventional 64
Observational 11

By Monocentric/Multicentric:

monocentric 49
multicentric2to4 7
multicentric5to9 2
multicentricup10 17

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening
NCT06512311 — brain neoplasms, pharmaceutical preparations, brain, neoplasms, drug evaluation, preclinical, glioblastoma, therapeutics
N/ARecruiting2024
Metabolic Control of Aging and Disease the MetAGE Deep Phenotyping Cohort
NCT06511297 — tomography, aging, brain, phenotype, magnetic resonance imaging, tomography, optical coherence, obesity, patient reported outcome measures, metabolic syndrome, male
N/ARecruiting2025

LeadR Networks

Main global connection map